Cutting-Edge Study on Ovarian PRP
Be Part of Groundbreaking Fertility Research
Platelet-Rich Plasma (PRP) is currently being studied in multiple fields of medicine. PRP therapy involves processing a patient’s own blood to extract a plasma component that contains concentrated platelets. This clinical trial seeks to evaluate PRP’s potential role in ovarian function by measuring its effects in a controlled research setting.
Generation Next Fertility is conducting a pioneering study on the benefits of Ovarian Platelet-Rich Plasma (oPRP) in IVF treatments. This cutting-edge research has the potential to redefine fertility care, and we want you to be a part of it!
By participating, you’ll not only contribute to groundbreaking advancements in reproductive medicine but also gain access to exceptional benefits designed to support your fertility journey.
Potential Benefits for Diminished Ovarian Reserve (DOR) & Failed IVF Cycles
This research focuses on improving outcomes for patients who may have experienced challenges with previous IVF cycles or have diminished ovarian reserve. Participation in this study offers the potential for: Improved IVF success rates, access to innovative oPRP treatments, and reduced IVF costs for qualifying participants.
Who is Eligible?